Gates (GTES) Q1 2026 Earnings Call Transcript

Gates Industrial reported Q1 revenue of $851 million with adjusted EBITDA of $177 million and EPS of $0.35, but results were temporarily pressured by ERP transition disruptions and two fewer working days. Management reiterated 2026 guidance, pointing to improving March/April demand, a book-to-bill ratio above 1, and Q2 revenue guidance of $905 million to $945 million. The company also announced a tuck-in acquisition of Timken’s Industrial Belt business, continued share repurchases, and cited strong free cash flow conversion of about 101% over the last 12 months.

Analysis

The setup is better than the headline quarter suggests: this is a clean example of a temporary operating disruption masking underlying demand acceleration. The important signal is that order intake is already outrunning billings while management is simultaneously recovering the European distribution lag, which creates a double tailwind into Q2/Q3 rather than a one-time catch-up. That matters because the market usually underestimates how much margin snaps back once ERP-related hypercare and shipping inefficiencies roll off, especially when price actions are layered on top of improving mix.

The second-order winner is not just GTES itself but its portfolio density in industrial OEM, aftermarket, and data-center liquid cooling. If data centers keep inflecting, this becomes a scarce-growth subsegment inside an otherwise mature cyclical, which should support a higher multiple than the market typically assigns to belt/power-transmission peers. The Timken belt deal is strategically more important than its revenue size implies: it is a capacity and SKU consolidation move that should lift North American share, remove a competitor, and provide a quick margin-repair lever once integrated onto Gates’ operating system.

The main risk is timing, not thesis. The stock can stall for 1-2 quarters if investors wait for proof that the ERP drag fully disappears and if industrial OEM or on-highway demand softens before the promised second-half margin expansion arrives. There is also an inflation/tariff call option embedded here: if input costs spike faster than pricing, near-term gross margin could compress even with stable demand, but management’s pricing discipline and supply-chain redundancy reduce the probability of a lasting hit.

Consensus is probably underestimating the operating leverage from Q2 onward. The market may anchor on the depressed reported EBITDA margin and miss that a normalized run-rate is moving toward the low-23% area, with upside if data center and Personal Mobility both reaccelerate simultaneously. That combination would justify multiple expansion because it shifts GTES from a post-reorg cyclically levered story to a self-help-plus-growth compounder.

Key Decisions for Investors

• Long GTES into Q2 earnings / post-ERP normalization, targeting a 3-6 month window; thesis is margin catch-up plus order-to-bill support. Risk: if Europe recovery is slower than management expects, the rerating gets delayed.
• Pair trade: long GTES / short TKR for 1-2 quarters. GTES has cleaner self-help, stronger data-center optionality, and a visible margin bridge; TKR is more exposed to a softer industrial re-rate and has less near-term operating inflection.
• Add GTES on any 5-8% pullback over the next month rather than chasing strength. The entry point matters because the stock should re-rate on proof, not promise, and the best risk/reward is before Q2 shipments fully show through.
• Buy GTES common plus out-of-the-money 6-12 month calls if volatility is reasonable. This captures upside if the second-half 23%+ EBITDA margin path and data-center momentum become more explicit, while capping downside premium outlay.
• If you want lower-beta exposure to the same theme, look for follow-through in suppliers tied to industrial automation / data-center cooling rather than broad cyclicals; the second-order read-through is that liquid-cooling adoption and industrial OEM restocking should support adjacent names over the next 2-4 quarters.